3rd Annual CBB Summit 2020

DESCRIPTION

On 18 & 19 June 2020, Porto, Portugal will host the BioTech Pharma Summit: CBB 2020 conference (Companion Diagnostics, Biomarkers & Biobanking). This year’s event will bring together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, Biobanking and leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the conference a perfect meeting-place to share experience, foster collaborations across industry and academia, evaluate emerging technologies and all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization.

Attending this Summit will provide you with the opportunity to mix and interact with experts working in all facets of Biomarkers & Biobanking through the individual, panel and roundtable discussions on offer. It is a Summit not to be missed.

The biomarkers market is projected to reach USD 53.34 Billion by 2021 from USD 27.95 Billion in 2016. Growth in the biomarkers market is mainly driven by factors such as increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker research. On the other hand, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage are the major factors restraining the growth of this market.

The CBB Summit provides two days of robust discussions on recent advancements and new strategies for development of new materials for global requirements.

The BioTech Pharma Summit: CDX, Biomarkers & Biobanking (CBB Summit) will insight into how the biobanking industry at the forefront at driving precision medicine and the opportunities and challenges of biomarker research discovery and development in a variety of therapeutic areas such as immune-oncology, neuroscience and cardio vascular disease areas, precision medicine, companion diagnostics, data integration methods, and utilising biomarkers in clinical trials. We will be gathering biobanking leaders from the north, as well as from across the Atlantic, in order to zoom in the market prospects and understand the dynamics of this fast-paced growing industry.

KEY PRACTICAL LEARNING POINTS

CDx & Biomarkers

  • Innovation in Digital Health for Personalized healthcare
  • Overcoming CDx regulatory issues; updates/future developments & accelerating development
  • Successful CDx collaborations & approvals
  • Overcoming CDx challenges
  • Biomarkers in Health and Disease
  • CDx Reimbursement, market access & commercialization
  • Next generation clinical trials for Precision Medicine
  • Molecular Diagnostics
  • Epidemiological Studies
  • Cancer Tissue Diagnostics
  • Translational Biomarkers in Drug Development
  • Clinical biomarker discovery
  • Artificial Intelligence and machine learning
  • Developing successful Rx-Dx partnerships, integration and co-development
  • Circulating Tumor Cells, Microvesicles, DNA and RNA – detection & monitoring

Biobanking

  • Biobanking Innovative models in precision medicine
  • IT Challenges and Solutions for Biobanks
  • Communication Strategies for Biobanking
  • Understand the opportunities and challenges of biosampling
  • Learn the latest technological methods and procedures for biopreservation, storage stability and validation
  • Quality Assessment & Management of Sample
  • Learn how to maintain a sustainable infrastructure in biobanking
  • Predict the market impact of biobanking in the next decade
  • Current market trends and future challenges for biobanking success
  • Biobanking development in emerging markets
  • Commercial challenges and opportunities
  • Clinical Trial Strategies in Biobanking and Drug Development

WHO SHOULD ATTEND?

The BioTech Pharma Summit (EPM Group) are exclusive events consisting of world-class keynote addresses and presentations designed specifically for senior level attendees from research & academic institutions, clinical research institutions and hospital laboratories as well as major pharmaceutical and biotech companies based Worldwide. Delegates typically include CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors of:

  • Assay Development
  • Biomarker Identification
  • Translational Medicine
  • Sample, Assay & Imaging Technologies
  • Vectorology & Biomarkers
  • Patient Stratification
  • Biobanking Researchers
  • Cryo storage Companies
  • Clinical Immunology
  • Clinical Pathologist
  • Metabolic Profiling
  • PK/PD
  • Bioinformatics
  • Precision Medicine
  • Genomics & Molecular Biology
  • Rx/Dx co-development
  • Regulatory Affairs
  • Regulatory Compliance
  • New Product Development
  • Pharmacodynamics
  • Biomarkers Non-Clinical Safety
  • Biomarker Development
  • Quantitative Biomarkers & Biomeasures
  • Biobanking
  • Molecular Technologies
  • Business Developers
  • Biobanking investors

After a sold-out event last year, we are back at it again, for a unique and extraordinary Biotech event!, guarantee your seat now!

Academic Package
Early Bird Rate

2-Days Summit

Full-Access to all Sessions

Coffee Breaks/Lunches

Event Certificate

Poster Presentation

500
Industry Package
Early Bird Rate

2-Days Summit

Full-Access to all Sessions

Coffee Breaks/Lunches

Gala Dinner

Unique 1-on-1 meetings

1,495
Premium Package
Early Bird Rate

2-Days Summit

Full-Access to all Sessions

Coffee Breaks/Lunches

Gala Dinner

Unique 1-on-1 meetings

Airport pick-up/drop-off

2-nights at the Hotel Venue

2,800
Exhibition Package
Best Choice

2-Days Summit

Full-Access to all Sessions

3m2 exhibition space

Logo on the conference website

25% discount for extra ticket

Unique 1-on-1 meetings

Gala Dinner

3,550
Event Details